Cart
sales@molnova.com
ND-011992
CAS No. 2446880-46-0
ND-011992( —— )
Catalog No. M36991 CAS No. 2446880-46-0
ND-011992 is a reversible and selective quinazoline inhibitor targeting quinone reductases and quinol oxidases.ND-011992 inhibits E. coli BL21*Δcyo respiratory complex I.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 141 | Get Quote |
|
| 5MG | 217 | Get Quote |
|
| 10MG | 312 | Get Quote |
|
| 25MG | 517 | Get Quote |
|
| 50MG | 730 | Get Quote |
|
| 100MG | 1017 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameND-011992
-
NoteResearch use only, not for human use.
-
Brief DescriptionND-011992 is a reversible and selective quinazoline inhibitor targeting quinone reductases and quinol oxidases.ND-011992 inhibits E. coli BL21*Δcyo respiratory complex I.
-
DescriptionND-011992 is a reversible, selective quinazoline-type inhibitor targeting quinone reductases and quinol oxidases. ND-011992 inhibits respiratory complex I and bo3 oxidase in addition to bd-I and bd-II oxidases in E. coli strain BL21*Δcyo with the IC50 of 0.12, 2.47, 0.63 and 1.3 μM, respectively. ND-011992 can be used for tuberculosis study.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMitochondrial Metabolism | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2446880-46-0
-
Formula Weight381.35
-
Molecular FormulaC21H14F3N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C=1C2=C(N=CN1)C=CC=C2)C3=CC=C(OC4=CC=C(C(F)(F)F)C=C4)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. K?gi J, et al. Exploring ND-011992, a quinazoline-type inhibitor targeting quinone reductases and quinol oxidases. Sci Rep. 2023;13(1):12226. Published 2023 Jul 28. doi:10.1038/s41598-023-39430-w?
molnova catalog
related products
-
L-Sulforaphane
(R)-Sulforaphane is a potent inducer of the Keap1/Nrf2/ARE pathway.
-
Phenazoline
Argireline a synthetic peptide which is patterned from the N-terminal end of the protein SNAP-25 can both reduce the degree of existing facial wrinkles and demonstrate effectively against their development.
-
Sari 59-801
Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).
